ArticleThe journal of pathology. Clinical research2024

Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.

Martyna Parol-Kulczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.